NCT00004081View on ClinicalTrials.gov

Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

January 31, 2002

Study Completion Date

March 31, 2003

Conditions
Ovarian CancerPeritoneal Cavity Cancer
Interventions
DRUG

docetaxel

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT00004081 - Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter